EUVIMEDEUVIMED entdecken
Crossref

Inhalable Polymeric PROTAC Nanococktail for Targeted Protein Degradation in Idiopathic Pulmonary Fibrosis

Qiaoling Tan, Yandong Zhao, Yangning Zhang, Hao Chen, Zhiqi Xu, Zhenhai Pan, Mohamed E El-Khouly iD, Youyong Yuan iD

Journal of the American Chemical Society · 08.07.2026 · 148 (26) · 27869-27883

DOI: 10.1021/jacs.6c09336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 24.06.2026. Verfasst von Qiaoling Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P. R. China. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Nanoparticles, Polymers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Guangdong Provincial Pearl River Talents Program, Guangzhou Municipal Science and Technology Project, National Basic Research Program of China (973 Program).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is sustained by a self-amplifying pathological circuit involving senescence-associated epithelial injury and fibroblast activation, which together drive persistent inflammatory signaling, excessive extracellular matrix deposition, and progressive loss of lung function. Although proteolysis-targeting chimeras (PROTACs) offer a powerful approach to eliminate disease-driving proteins, their application in fibrotic lung disease remains limited by inefficient pulmonary delivery, poor lesion retention, and insufficient intervention in multicellular profibrotic networks. Herein, we develop an inhalable enzyme-activated polymeric PROTAC nanococktail that enables concurrent degradation of two key profibrotic signaling regulators in fibrotic lungs. The nanococktail consists of GAL@SD and FAP@BD, two disease-microenvironment-responsive nanoparticles carrying distinct PROTAC cargos. GAL@SD responds to elevated senescence-associated β-galactosidase activity in fibrotic lungs and releases a stimulator of interferon genes (STING)-degrading PROTACs to suppress senescence-associated inflammatory signaling linked to impaired alveolar epithelial repair. FAP@BD is activated by fibroblast activation protein-α enriched in activated fibroblast-dominated fibrotic regions, delivering a bromodomain-containing protein 4 (BRD4)-degrading PROTAC to inhibit myofibroblast activation and extracellular matrix production. After inhalation, both nanoparticles exhibit efficient mucus penetration, improved pulmonary retention, and preferential accumulation in fibrotic lesions, enabling localized degradation of STING and BRD4. In a bleomycin-induced mouse model of pulmonary fibrosis, the combined PROTAC nanococktail achieves superior therapeutic efficacy compared with either single PROTAC nanoparticle, as demonstrated by restored lung architecture, improved respiratory function, reduced collagen deposition, and reversal of fibrosis-associated transcriptional programs. These results demonstrate an inhaled dual-PROTAC nanotherapeutic strategy for simultaneously attenuating epithelial senescence-associated inflammation and fibroblast-driven matrix remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisNanoparticlesPolymersProteolysis Targeting ChimeraAnimalsHumansMiceProteolysisAdministration, InhalationFibroblast Activation Protein AlphaBromodomain Containing ProteinsTranscription Factors

Substanzen

Proteolysis Targeting ChimeraPolymersFibroblast Activation Protein AlphaBromodomain Containing ProteinsTranscription Factors

Autor:innen und Institutionen

  • School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, P. R. China.
  • Department of Pathology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, P. R. China.
  • Nanoscience Program, Institute of Basic and Applied Science, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, Alexandria 21934, Egypt.
  • National Engineering Research Center for Tissue Restoration and Reconstruction, and Key Laboratory of Biomedical Materials of the Ministry of Education, South China University of Technology, Guangzhou 510006, P. R. Chin…
  • Key Laboratory of Biomedical Engineering of Guangdong Province, South China University of Technology, Guangzhou 510006, P. R. China.

ORCID-Profile: Mohamed E El-Khouly, Youyong Yuan

Förderung

  • Guangdong Provincial Pearl River Talents Program
  • Guangzhou Municipal Science and Technology Project
  • National Basic Research Program of China (973 Program)
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Tan, Q., Zhao, Y., Zhang, Y., Chen, H., Xu, Z., Pan, Z., El-Khouly, M. E., & Yuan, Y. (2026). Inhalable Polymeric PROTAC Nanococktail for Targeted Protein Degradation in Idiopathic Pulmonary Fibrosis. Journal of the American Chemical Society, 148(26), 27869-27883. https://doi.org/10.1021/jacs.6c09336

Vancouver

Tan Q, Zhao Y, Zhang Y, Chen H, Xu Z, Pan Z, et al. Inhalable Polymeric PROTAC Nanococktail for Targeted Protein Degradation in Idiopathic Pulmonary Fibrosis. Journal of the American Chemical Society. 2026;148(26):27869-27883. doi:10.1021/jacs.6c09336

BibTeX
@article{Tan2026,
  author = {Tan, Qiaoling and Zhao, Yandong and Zhang, Yangning and Chen, Hao and Xu, Zhiqi and Pan, Zhenhai and El-Khouly, Mohamed E and Yuan, Youyong},
  title = {Inhalable Polymeric PROTAC Nanococktail for Targeted Protein Degradation in Idiopathic Pulmonary Fibrosis},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {26},
  pages = {27869--27883},
  doi = {10.1021/jacs.6c09336}
}
Kostenlos starten →